Treatment according to guidelines may bridge the gender gap in outcome for patients with stage T1 urinary bladder cancer

References

• Babjuk M, Bohle A, Burger M, et al. EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016. Eur Urol. 2017;71:447–461.
   PubMed Web of Science ®Google Scholar
• Thorstenson A, Hagberg O, Ljungberg B, et al. Gender-related differences in urothelial carcinoma of the bladder: a population-based study from the Swedish National Registry of Urinary Bladder Cancer. Scand J Urol. 2016;50:292–297.
   PubMed Web of Science ®Google Scholar
• Mungan NA, Aben KK, Schoenberg MP, et al. Gender differences in stage-adjusted bladder cancer survival. Urology. 2000;55:876–880.
   PubMed Web of Science ®Google Scholar
• Waldhoer T, Berger I, Haidinger G, et al. Sex Differences of >/= pT1 bladder cancer survival in Austria: a descriptive, long-term, nation-wide analysis based on 27,773 patients. Urol Int. 2015;94:383–389.
   PubMed Web of Science ®Google Scholar
• Donsky H, Coyle S, Scosyrev E, et al. Sex differences in incidence and mortality of bladder and kidney cancers: national estimates from 49 countries. Urol Oncol. 2014;32:40. e23–31.
   Web of Science ®Google Scholar
• Malmstrom PU, Thorn M, Lindblad P, et al. Increasing survival of patients with urinary bladder cancer. a nationwide study in Sweden 1960–1986. Eur J Cancer. (Oxford, England: 1990). 1993;29a:1868–1872.
   PubMed Web of Science ®Google Scholar
• Kluth LA, Fajkovic H, Xylinas E, et al. Female gender is associated with higher risk of disease recurrence in patients with primary T1 high-grade urothelial carcinoma of the bladder. World J Urol. 2013;31:1029–1036.
   PubMed Web of Science ®Google Scholar
• Report from The Swedish National Registry of Urinary Bladder Cancer (SNRUBC). 2015. Available from:https://www.cancercentrum.se
   Google Scholar
• Puente D, Malats N, Cecchini L, et al. Gender-related differences in clinical and pathological characteristics and therapy of bladder cancer. Eur Urol. 2003;43:53–62.
   PubMed Web of Science ®Google Scholar
• Boorjian SA, Zhu F, Herr HW. The effect of gender on response to bacillus Calmette-Guérin therapy for patients with non-muscle-invasive urothelial carcinoma of the bladder. Bju Int. 2010;106:357–361.
   PubMed Web of Science ®Google Scholar
• Noon AP, Albertsen PC, Thomas F, et al. Competing mortality in patients diagnosed with bladder cancer: evidence of undertreatment in the elderly and female patients. Br J Cancer. 2013;108:1534–1540.
   PubMed Web of Science ®Google Scholar
• Gontero P, Sylvester R, Pisano F, et al. Prognostic factors and risk groups in T1G3 non-muscle-invasive bladder cancer patients initially treated with Bacillus Calmette-Guérin: results of a retrospective multicenter study of 2451 patients. Eur Urol. 2015;67:74–82.
   PubMed Web of Science ®Google Scholar
• Jahnson S, Hosseini Aliabad A, Holmang S, et al. Swedish National Registry of Urinary Bladder Cancer: no difference in relative survival over time despite more aggressive treatment. Scand J Urol. 2016;50:14–20.
   PubMed Web of Science ®Google Scholar
• Cohn JA, Vekhter B, Lyttle C, et al. Sex disparities in diagnosis of bladder cancer after initial presentation with hematuria: a nationwide claims-based investigation. Cancer. 2014;120:555–561.
   PubMed Web of Science ®Google Scholar
• Henning A, Wehrberger M, Madersbacher S, et al. Do differences in clinical symptoms and referral patterns contribute to the gender gap in bladder cancer? BJU Int. 2013;112:68–73.
   PubMed Web of Science ®Google Scholar
• Garg T, Pinheiro LC, Atoria CL, et al. Gender disparities in hematuria evaluation and bladder cancer diagnosis: a population based analysis. J Urol. 2014;192:1072–1077.
   PubMed Web of Science ®Google Scholar
• Mansson A, Anderson H, Colleen S. Time lag to diagnosis of bladder cancer–influence of psychosocial parameters and level of health-care provision. Scand J Urol. 1993;27:363–369.
   Web of Science ®Google Scholar
• Ide H, Inoue S, Miyamoto H. Histopathological and prognostic significance of the expression of sex hormone receptors in bladder cancer: a meta-analysis of immunohistochemical studies. PLoS One. 2017;12:e0174746.
   PubMed Web of Science ®Google Scholar
• Sikic D, Breyer J, Hartmann A, et al. High androgen receptor mRNA expression is independently associated with prolonged cancer-specific and recurrence-free survival in stage T1 bladder cancer. Transl Oncol. 2017;10:340–345.
   PubMed Web of Science ®Google Scholar
• Dobruch J, Daneshmand S, Fisch M, et al. Gender and bladder cancer: a collaborative review of etiology, biology, and outcomes. Eur Urol. 2016;69:300–310.
   PubMed Web of Science ®Google Scholar
• Shang Z, Li Y, Zhang M, et al. Antiandrogen therapy with hydroxyflutamide or androgen receptor degradation enhancer ASC-J9 enhances BCG efficacy to better suppress bladder cancer progression. Mol Cancer Ther. 2015;14:2586–2594.
   PubMed Web of Science ®Google Scholar
• Shang Z, Li Y, Hsu I, et al. Targeting estrogen/estrogen receptor alpha enhances Bacillus Calmette-Guerin efficacy in bladder cancer. Oncotarget. 2016;7:27325–27335.
   PubMedGoogle Scholar
• Eriksson P, Aine M, Veerla S, et al. Molecular subtypes of urothelial carcinoma are defined by specific gene regulatory systems. BMC Med Genomics. 2015;8:25.
   PubMed Web of Science ®Google Scholar
• Patschan O, Sjodahl G, Chebil G, et al. A molecular pathologic framework for risk stratification of stage T1 urothelial carcinoma. Eur Urol. 2015;68:824–832. discussion 835–836.
   PubMed Web of Science ®Google Scholar
• Otto W, Denzinger S, Fritsche HM, et al. The WHO classification of 1973 is more suitable than the WHO classification of 2004 for predicting survival in pT1 urothelial bladder cancer. BJU Int. 2011;107:404–408.
   PubMed Web of Science ®Google Scholar
• May M, Brookman-Amissah S, Roigas J, et al. Prognostic accuracy of individual uropathologists in noninvasive urinary bladder carcinoma: a multicentre study comparing the 1973 and 2004 World Health Organisation classifications. Eur Urol. 2010;57:850–858.
   PubMed Web of Science ®Google Scholar